Effects of Gluten Digestion With ALV003
NCT00859391 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2009-06-11
Summary
This is a Phase 0, Double-blind study that will assess the effect of in vitro treatment of gluten with ALV003 or with placebo when ingested by CD Subjects.
Conditions
Sponsors & Collaborators
-
Alvine Pharmaceuticals Inc.
lead INDUSTRY
Principal Investigators
-
Gregor Brown, MD · The Alfred
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2008-06-30
- Completion
- 2008-06-30
Countries
- Australia
Study Locations
More Related Trials
-
Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease
NCT06982963 ·Status: RECRUITING ·Phase: PHASE2
-
Gastric Gluten-Degradation Activity of PvP001
NCT03594331 ·Status: TERMINATED ·Phase: PHASE1
-
Safety Study of Larazotide Acetate to Treat Celiac Disease.
NCT00386165 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Patients With Non-coeliac Gluten Sensitivity
NCT03798249 ·Status: UNKNOWN ·Phase: NA
-
Latiglutenase as a Treatment for Celiac Disease
NCT03585478 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease
NCT00492960 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Healthy Subjects
NCT03798262 ·Status: COMPLETED ·Phase: NA
-
Impact of Gluten Contamination in Celiac Patients Clinically Responsive and Unresponsive to the Gluten-free Diet
NCT05066191 ·Status: UNKNOWN
-
Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients
NCT04243551 ·Status: TERMINATED ·Phase: PHASE2
-
RCT: Effect of Late vs Early Introduction of Gluten-free Oats on Patients With Newly Diagnosed Celiac Disease.
NCT05803408 ·Status: RECRUITING ·Phase: NA
-
Changes in Intestinal Permeability 4 Hours After Gluten Challenge
NCT03288831 ·Status: COMPLETED ·Phase: NA
-
Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease
NCT00889473 ·Status: COMPLETED ·Phase: PHASE2
-
Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo
NCT02472704 ·Status: COMPLETED ·Phase: NA
-
Study of Latiglutenase in T1D/CD Patients
NCT04839575 ·Status: TERMINATED ·Phase: PHASE2
-
Digestion of Gluten in the Presence of Enzymes
NCT04489810 ·Status: COMPLETED ·Phase: NA
-
A Phase II Study of CCX282-B in Patients With Celiac Disease
NCT00540657 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Response in Celiac Disease on In-vitro Gluten Challenge
NCT01909050 ·Status: COMPLETED
-
A Study of PVP001, PVP002, and PVP003 in Healthy Adults and PVP001 and PVP002 in Adults With Celiac Disease
NCT03701555 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease
NCT02528799 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
NCT03644069 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
NCT03409796 ·Status: COMPLETED ·Phase: NA
-
Risk of Celiac Disease and Age at Gluten Introduction
NCT00639444 ·Status: COMPLETED ·Phase: NA
-
PRV-015 in Gluten-free Diet Non-responsive Celiac Disease
NCT04424927 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Gluten on Gut Microbiome and Metabolic Health.
NCT01719913 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease
NCT03521180 ·Status: COMPLETED